Neuromuscular effects of candoxin, a novel toxin from the venom of the Malayan krait (Bungarus candidus).

No Thumbnail Available
File version
Author(s)
Nirthanan, S
Charpantier, E
Gopalakrishnakone, P
Gwee, MCE
Khoo, HE
Cheah, LS
Kini, RM
Bertrand, D
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2003
Size
File type(s)
Location
License
Abstract

1 Candoxin (MW 7334.6), a novel toxin isolated from the venom of the Malayan krait Bungarus candidus, belongs to the poorly characterized subfamily of nonconventional three-finger toxins present in Elapid venoms. The current study details the pharmacological effects of candoxin at the neuromuscular junction. 2 Candoxin produces a novel pattern of neuromuscular blockade in isolated nerve-muscle preparations and the tibialis anterior muscle of anaesthetized rats. In contrast to the virtually irreversible postsynaptic neuromuscular blockade produced by curaremimetic a-neurotoxins, the neuromuscular blockade produced by candoxin was rapidly and completely reversed by washing or by the addition of the anticholinesterase neostigmine. 3 Candoxin also produced significant train-of-four fade during the onset of and recovery from neuromuscular blockade, both, in vitro and in vivo. The fade phenomenon has been attributed to a blockade of putative presynaptic nicotinic acetylcholine receptors (nAChRs) that mediate a positive feedback mechanism and maintain adequate transmitter release during rapid repetitive stimulation. In this respect, candoxin closely resembles the neuromuscular blocking effects of d-tubocurarine, and differs markedly from curaremimetic a-neurotoxins that produce little or no fade. 4 Electrophysiological experiments confirmed that candoxin produced a readily reversible blockade (IC50~10 nM) of oocyte-expressed muscle (a߿d) nAChRs. Like a-conotoxin MI, well known for its preferential binding to the a/d interface of the muscle (a߿d) nAChR, candoxin also demonstrated a biphasic concentration - response inhibition curve with a high- (IC50~2.2 nM) and a low-(IC50~98 nM) affinity component, suggesting that it may exhibit differential affinities for the two binding sites on the muscle (a߿d) receptor. In contrast, curaremimetic a-neurotoxins have been reported to antagonize both binding sites with equal affinity.

Journal Title

British Journal of Pharmacology

Conference Title
Book Title
Edition
Volume

139

Issue

4

Thesis Type
Degree Program
School
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Pharmacology and pharmaceutical sciences

Basic pharmacology

Persistent link to this record
Citation
Collections